sotagliflozin

Lexicon slams FDA over hearing denial following a CRL for its SGLT2 inhibitor candidate
Endpoints
Wed, 11/30/22 - 08:01 pm
Lexicon Pharmaceuticals
FDA
type 1 diabetes
sotagliflozin
Will third time be the charm? Lexicon finally refiles SGLT2 drug for heart failure
Endpoints
Tue, 05/31/22 - 11:58 pm
Lexicon Pharmaceuticals
sotagliflozin
heart failure
FDA
ACC: Lexicon hopes sotagliflozin cardio data will set its drug apart from SGLT2 rivals
Fierce Pharma
Mon, 04/4/22 - 10:59 am
Lexicon Pharmaceuticals
ACC
diabetes
sotagliflozin
type 2 diabetes
heart failure
3 Biotech Stocks That Jumped Last Week
Motley Fool
Sun, 01/17/21 - 04:54 pm
biotech
biotech stocks
Lexicon Pharmaceuticals
sotagliflozin
Nucana
Aldeyra Therapeutics
reproxalap
AHA 2020 – sotagliflozin wins come too late for Lexicon
EP Vantage
Tue, 11/17/20 - 10:45 am
Lexicon Pharmaceuticals
sotagliflozin
AHA
heart failure
chronic kidney disease
What's Next for Lexicon Pharmaceuticals?
Motley Fool
Mon, 03/25/19 - 10:21 pm
Lexicon Pharmaceuticals
sotagliflozin
Zynquista
Sanofi
diabetes
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
Pharmaforum
Fri, 01/18/19 - 10:26 am
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
Zynquista
FDA
advisory panels
sotagliflozin
Sanofi seeks to restore leadership in diabetes treatments
GoinPharma
Sat, 03/31/18 - 09:59 am
Sanofi
diabetes
sotagliflozin
Sanofi/Lexicon’s sotagliflozin filed in US and EU for type 1 diabetes
Pharmaforum
Fri, 03/30/18 - 06:02 pm
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
sotagliflozin
First Oral Drug for Type 1 Diabetes Could be Available in 2018
Xtalks
Sat, 09/16/17 - 11:54 am
type 1 diabetes
sotagliflozin
Sanofi
Lexicon Pharmaceuticals
With an eye on the FDA, Lexicon and Sanofi line up more positive data on diabetes drug
Endpoints
Tue, 08/15/17 - 10:49 am
FDA
Lexicon Pharmaceuticals
Sanofi
type 1 diabetes
sotagliflozin
Lexicon Pharma Goes Three For Three With Sotagliflozin Data
Seeking Alpha
Tue, 06/13/17 - 12:06 pm
Lexicon Pharmaceuticals
sotagliflozin
type 1 diabetes
Sanofi
Lexicon diabetes pill hits endpoint in another phase 3, teeing up regulatory filings by partner Sanofi
Fierce Biotech
Fri, 06/9/17 - 11:02 am
Lexicon Pharmaceuticals
diabetes
clinical trials
sotagliflozin
Sanofi
3 Tremendously Promising Diabetes Drugs Potentially on the Way
Motley Fool
Sun, 03/26/17 - 12:02 pm
diabetes
ertugliflozin
Merck
Pfizer
sotagliflozin
Sanofi
Lexicon Pharmaceuticals
semaglutide
Novo Nordisk
Lexicon's Phase 2 Diabetes Study Looks Good
Investopedia
Wed, 10/26/16 - 08:49 am
Lexicon Pharmaceuticals
sotagliflozin
type 1 diabetes
diabetes
Can Lexicon Pharmaceuticals Make Any Progress In Diabetes On Safety?
Seeking Alpha
Tue, 06/9/15 - 09:35 am
Lexicon Pharmaceuticals
diabetes
sotagliflozin